imipramine has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishida, A; Shimizu, M; Yamawaki, S | 1 |
| Akaboshi, S; Higaki, K; Katsumoto, T; Ohno, K; Sakuraba, H; Sato, M; Tai, T; Taniguchi, M | 1 |
| Kamei, K; Muneoka, K; Muraoka, S; Takigawa, M | 1 |
3 other study(ies) available for imipramine and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
| Article | Year |
|---|---|
Forskolin and phorbol myristate acetate inhibit intracellular Ca2+ mobilization induced by amitriptyline and bradykinin in rat frontocortical neurons.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Methyl-3-isobutylxanthine; Amitriptyline; Animals; Bradykinin; Bucladesine; Calcium; Cells, Cultured; Colforsin; Cyclic AMP; Frontal Lobe; Imipramine; Inositol 1,4,5-Trisphosphate; Isoquinolines; Kinetics; Neurons; Piperazines; Protein Kinase Inhibitors; Rats; Tetradecanoylphorbol Acetate | 1993 |
Accumulation of cholesterol and GM2 ganglioside in cells cultured in the presence of progesterone: an implication for the basic defect in Niemann-Pick disease type C.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Biological Transport; Cells, Cultured; Cholesterol; Fibroblasts; Fluorescent Antibody Technique; G(M2) Ganglioside; Humans; Imipramine; Niemann-Pick Diseases; Progesterone; Rats | 1998 |
Chronic imipramine administration amplifies the serotonin2A receptor-induced intracellular Ca2+ mobilization in C6 glioma cells through a calmodulin-dependent pathway.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Catecholamines; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Synergism; Glioma; Imipramine; Intracellular Fluid; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Signal Transduction; Time Factors; Tumor Cells, Cultured | 1998 |